Norry Elliot
SEC insider (Form 3/4/5 filer). CIK 0001798117. Chief Medical Officer at Adaptimmune Therapeutics PLC (ADAP). 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 20, 2025. Located in ABINGDON, X0.
Companies Norry Elliot has filed insider reports for
- Adaptimmune Therapeutics PLC (ADAP): Officer, Chief Medical Officer
Norry Elliot
CIK: 0001798117
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Adaptimmune Therapeutics PLC
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 20, 2025ADAP
Adaptimmune Therapeutics PLC
AwardDirectOption to purchase Ordinary Shares
1.6M shares- - Feb 20, 2025ADAP
Adaptimmune Therapeutics PLC
AwardDirectOption to purchase Ordinary Shares
1.1M shares- - Jan 17, 2025ADAP
Adaptimmune Therapeutics PLC
SaleDirect5.6K shares at avg. $0.58$3K - Jan 15, 2025ADAP
Adaptimmune Therapeutics PLC
SaleDirect9.8K shares at avg. $0.57$6K - Jan 13, 2025ADAP
Adaptimmune Therapeutics PLC
SaleDirect4.3K shares at avg. $0.59$3K - Jan 13, 2025ADAP
Adaptimmune Therapeutics PLC
SaleDirect8.1K shares at avg. $0.59$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 20, 2025 | ADAP Adaptimmune Therapeutics PLC | Award Option to purchase Ordinary Shares | 1,612,032 | - | - | Direct |
| Feb 20, 2025 | ADAP Adaptimmune Therapeutics PLC | Award Option to purchase Ordinary Shares | 1,074,696 | - | - | Direct |
| Jan 17, 2025 | ADAP Adaptimmune Therapeutics PLC | Sale | 5,584 | $0.58 | $3,243 | Direct |
| Jan 15, 2025 | ADAP Adaptimmune Therapeutics PLC | Sale | 9,803 | $0.57 | $5,635 | Direct |
| Jan 13, 2025 | ADAP Adaptimmune Therapeutics PLC | Sale | 4,268 | $0.59 | $2,509 | Direct |
| Jan 13, 2025 | ADAP Adaptimmune Therapeutics PLC | Sale | 8,124 | $0.59 | $4,776 | Direct |
1-6 of 6 transactions